IM Cannabis Appoints Asi Levi as Chief Financial Officer

IM Cannabis (Nasdaq: IMCC) appointed Asi Levi, CPA as Chief Financial Officer effective December 12, 2025, replacing Uri Birenberg.

Rhea-AI Summary

IM Cannabis (Nasdaq: IMCC) appointed Asi Levi, CPA as Chief Financial Officer effective December 12, 2025, replacing Uri Birenberg.

Mr. Levi has over 15 years of finance experience, including prior CFO roles at Water Ways Technologies and DekelOil CI and controller roles at SciSparc and A2Z Cust2Mate. The company said he oversaw fundraising, financial planning, budgeting and cash flow management under IFRS and other standards. The company thanked Mr. Birenberg for his service and wished him success in future endeavors.

Positive

• New CFO appointment effective December 12, 2025
• 15+ years of finance and controlling experience
• Prior CFO roles at Water Ways Technologies and DekelOil CI
• IFRS experience in fundraising and financial planning

Negative

• Immediate CFO replacement may create short-term transition risk

Argus Dec 15 session

-19.15% close to close Open Argus

Details

News Market Reaction – IMCC

On Dec 15, the first trading day after this news, IMCC closed 19.15% below the previous close.

Data tracked by StockTitan Argus for the Dec 15 session.

Market Context

On Dec 15, the first trading day after this news, the stock closed 19.1% below the previous close. A...

Analysis

On Dec 15, the first trading day after this news, the stock closed 19.1% below the previous close. A negative reaction despite the CFO appointment fits a backdrop of prior losses, higher operating expenses, and a recent going concern disclosure. Investors may remain focused on balance sheet constraints and execution risk rather than management changes alone. The unused $50 million F-3 shelf and earlier warrant amendments underscore potential future dilution, which could weigh on sentiment even when governance news appears constructive.

Key Figures

Finance experience: over 15 years

Finance experience

over 15 years

Asi Levi’s experience in finance and controlling roles

Historical Context

5 past events · Latest: Nov 13

5 events

1. Nov 13

   Q3 2025 earnings

   24h Move

   -9.0%

   Weak margins, higher expenses, net loss and going concern disclosure.

2. Nov 06

   Earnings date notice

   24h Move

   -0.8%

   Announcement of timing for Q3 2025 financial and operational results.

3. Oct 29

   CFO departure

   24h Move

   +0.0%

   CFO stepping down for personal reasons with planned transition period.

4. Oct 23

   Acquisition term sheet

   24h Move

   -9.7%

   Non-binding deal to buy 60% of quantum computing bio data company.

5. Sep 16

   Board and strategy

   24h Move

   +1.6%

   New board members and chairman plus pursuit of additional opportunities.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

international financial reporting standards (IFRS), IFRS

2 terms

international financial reporting standards (IFRS) financial

"cash flow management in compliance with international financial reporting standards (IFRS)"

A set of globally accepted accounting rules companies use to prepare financial statements so their numbers speak the same language across borders. For investors, IFRS matters because it makes it easier to compare profitability, assets and liabilities between companies the way a common recipe or measuring tape lets you judge two cakes or two rooms fairly, which helps assess value and risk more reliably.

IFRS financial

"cash flow management in compliance with international financial reporting standards (IFRS)"

International Financial Reporting Standards (IFRS) are a set of common accounting rules used by many companies worldwide to prepare financial statements, so numbers like revenue, profit and assets are measured in the same way across borders. For investors, IFRS matters because it makes it easier to compare the financial health and performance of different companies—like using the same ruler to measure different objects—reducing surprises and helping informed investment decisions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

TORONTO and GLIL YAM, Israel, Dec. 12, 2025 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, today announced, further to its press release dated October 29, 2025, the appointment of Asi Levi, CPA, as the Company's Chief Financial Officer ("CFO"), effective immediately, to replace Uri Birenberg.

Mr. Levi has over 15 years of experience in finance and controlling roles, including serving as Chief Financial Officer of Water Ways Technologies Inc. and DekelOil CI, part of Dekel Agri-Vision Plc and as Controller of SciSparc Ltd. and A2Z Cust2Mate Solutions Corp. He has overseen fundraising efforts and handled financial planning, budgeting, and cash flow management in compliance with international financial reporting standards (IFRS) and other standards.

The Company thanks Mr. Birenberg for his contributions during his tenure as CFO and wishes him success in his future endeavors. 

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has focused its resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its subsidiaries, which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients.

Company Contact:

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
a.taranko@imcannabis.de

Oren Shuster, Chief Executive Officer
IM Cannabis Corp.
info@imcannabis.com

Logo - https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/im-cannabis-appoints-asi-levi-as-chief-financial-officer-302640165.html

SOURCE IM Cannabis Corp.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who is the new CFO of IM Cannabis (IMCC) as of December 12, 2025?

Asi Levi, CPA was appointed Chief Financial Officer effective December 12, 2025.

Which executive did Asi Levi replace at IM Cannabis (IMCC)?

Asi Levi replaced Uri Birenberg as Chief Financial Officer.

What relevant experience does IM Cannabis CFO Asi Levi have for IMCC investors?

He has over 15 years in finance, prior CFO roles and IFRS experience in fundraising and planning.

When did IM Cannabis announce the appointment of its new CFO (IMCC)?

The appointment was announced on December 12, 2025 and is effective immediately.

Will the IM Cannabis CFO change (IMCC) affect financial reporting processes?

The company highlighted Asi Levi's IFRS experience, indicating continuity in international reporting practices.